Elevating Commercialization in China Part 1: The Path to Launch

Home / Intelligence / Webinars / Elevating Commercialization in China Part 1: The Path to Launch

Available On Demand

The pharmaceutical market in China has experienced tremendous growth over the past several decades and is becoming increasingly important. While many life sciences organizations consider China to be a ‘must win’ market, commercial success can be elusive. Despite the large patient base and recent economic and political tailwinds driving the advancement of the healthcare industry, sales for innovative drugs in China are often only a fraction of those in the U.S. The complex and rapidly evolving market dynamics require companies to stay on the cutting edge of new regulatory pathways, pricing/market access and go-to-market models.    

Join Trinity Life Sciences’ APAC experts as they explore the key dynamics of the pharmaceutical market in China and uncover multiple strategies and levers that can elevate commercial success in this market.

In this three-part webinar series, our experts will explore:

Part 1: The Path to Launch | Available On Demand
Leveraging novel commercialization pathways for innovative therapies

Part 2: The Key to Pricing & Access Optimization | October 18th or 19th
Decoding the current dynamics and future trends of Pricing and Market Access

Part 3: The Winning Commercial Model | Upcoming
Building a model to match China’s changing dynamics

Key Topics Covered In Part 1:

  • Regulatory pathways to accelerate commercial launch in China
  • Balancing pros and cons 
  • Insights from recent launches 

Featuring


Complete the form below to view the on-demand webinar:

By submitting this form, creating an account, and/or using our website (or using our Services) you agree to our Privacy Policy. Information provided by you is stored in our database and may be used for sending you additional information about Trinity (including Trinity’s partners and affiliates) and our products and services. Such information may be transferred for this purpose to Trinity and affiliates in other countries. If you would like to opt out in the future, please email _compliance@trinitylifesciences.com.

This webinar will be hosted within the ON24 platform, which requires the usage of Javascript and Cookies. Please see ON24’s Privacy Policy for more information.

Related Intelligence

Webinars

2023 NRDL Update: An Ongoing Voyage of Innovation and Accessibility

May 1, 2024 | 12:00 – 12:45 PM ET / 18:00 – 18:45 CET

An additional session will be offered on May 7th at 16:00-16:45 (UTC+8:00) – Asia/Shanghai How can manufacturers strategize for pricing and market access success amidst the evolving landscape of China’s NRDL? As China continues to be a key pharmaceutical market, understanding the latest National Reimbursement Drug List (NRDL) trends and policy evolvement is crucial for […]

 Sign Up Now

Blog

Rise with the waves: Italy – AIFA restructuring and budget reforms – Stepping into a new (uncertain) future?

Executive Summary The Italian Medicines Agency (AIFA) underwent transformative changes on January 30, 2024, following a much-anticipated reorganization. AIFA’s restructuring has already faced challenges, with the recent resignation of the newly created Scientific and Economic Commission’s (CSE) chairman followed by the appointment of a new acting chairman, highlighting the need for a stable and collaborative […]

 Read More

Webinars

Annual State of Global Market Access Webinar

Available On Demand

Trinity Life Sciences is pleased to release our highly anticipated white paper, the Annual State of Global Market Access. This year’s white paper focuses on six key global market access trends and provides payer perspectives on these trends. We explore the consequences of new therapeutic advances and policies aiming to control costs globally and the […]

 Watch Now